GlassScriptPhysician profile
Nam T Tran
NPI 1083604078
$9,706.63
in general payments reported to CMS, 2019-2025
11 companies · $2,547 in 2025
The $2,547 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $901 · 2020: $165 · 2021: $2,644 · 2022: $434 · 2023: $603 · 2024: $2,414 · 2025: $2,547.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,274 · Travel and Lodging: $2,289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,274.38 |
| Travel and Lodging | $2,289.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,823.84 | 2021-2025 | Signia, Na, Endurant Iis |
| Silk Road Medical, INC. | $1,804.62 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Balt USA, LLC | $1,225.55 | 2022-2025 | Prestige Coil System |
| Medtronic Vascular, INC. | $627.92 | 2019-2020 | |
| Penumbra, INC. | $312.88 | 2019 | |
| Shape Memory Medical INC. | $299.13 | 2025 | Impede Embolization Plug |
| Abbott Laboratories | $215.70 | 2024-2025 | Esprit |
| Inspiremd LTD | $163.31 | 2025 | Cguard Prime Carotid Stent System |
| Cook Medical LLC | $124.61 | 2019 | |
| Bolton Medical INC | $92.32 | 2025 | Relay Thoracic Stent-Graft With Plus Delivery System |
| W. L. Gore & Associates, INC. | $16.75 | 2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nam Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.